Michael P. Dube, VP, Chief Accounting Officer: Intellia Therapeutics NTLA Sell · Filed 01/07

Trade details

Type: Insider sale
Amount: $27,528.69
Shares · price: 2,989 sh · $9.21 a share
Held after: 52,277 sh
Stock: Intellia Therapeutics NTLA
Person: Michael P. DubeVP, Chief Accounting Officer
Trade date: 26/01/05
Filed: 26/01/07
Days to filing: 2 days

Sold 5.4% of holdings

Share of holding sold: 5.4%

Intellia Therapeutics trades, last 26 weeks

What else happened in Intellia Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/06~02/04

Michael P. Dube's recent trades

Michael P. DubeVP, Chief Accounting Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$32.5K
1,871 sh
$32.5K
Filed 25/10/03
Traded 25/10/01
Michael P. DubeVP, Chief Accounting Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$24.9K
2,503 sh
$24.9K
Filed 25/07/03
Traded 25/07/02
Michael P. DubeVP, Chief Accounting Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$16.7K
1,372 sh
$16.7K
Filed 25/01/07
Traded 25/01/03
Michael P. DubeVP, Chief Accounting Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$38.2K
2,012 sh
$38.2K
Filed 24/10/04
Traded 24/10/02